Drugs with this side effect as MedDRA Preferred Term
- 1,25(OH)2D3
- Erythema: postmarketing
- Redness
- 17-hydroxyprogesterone
- 2-hydroxysuccinaldehyde
- 5-ASA
- 5-FU
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- Erythema: common, 0% - 16.8%
- 68Ga
- 8-MOP
- ACTH(1-39
- Erythema facial: postmarketing
- AMD3100
- Almeta
- Anidulafungin
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Azarga
- BCNU
- Buscopan
- CAS 76095-16-4
- CGP 19835A
- Cancidas
- DFMO
- Erythema: 0% - 2.5%
- Redness: 0% - 2.5%
- Enfuvirtide
- FK463
- FdUrd
- Fe(III
- Erythema: postmarketing
- Redness
- Forteo
- Gd-DTPA
- Ge-132
- Glat copolymer
- Goserelin
- Histrelin
- Humalog
- Implanon
- Insulin
- K779
- LMWH
- LY146032
- Erythema: postmarketing, 5% - 5.2%
- Lantus
- Leuprorelin
- Lisinopril
- Mersyndol
- Metrodin
- Erythema
- Redness: postmarketing
- N-acetylcysteine
- NovoLog
- Octreotide
- Optison
- Erythema: postmarketing, rare
- Org 37462
- PEP005
- PGE1
- Photofrin
- SOM230
- SU5416
- T-A2-3
- Vancocine
- Westcort
- acarbose
- acetaminophen
- acipimox
- acitretin
- actinomycin D
- acyclovir
- adapalene
- Erythema: 0% - 26.1%
- Redness: very common
- alclometasone
- alendronate
- alfentanil
- aliskiren
- Erythema: postmarketing, rare
- almotriptan
- Erythema: postmarketing, rare
- amiodarone
- ammonium lactate
- amorolfine
- amphotericin B
- anastrozole
- anthracycline
- apraclonidine
- aprepitant
- aripiprazole
- arsenic
- arsenic trioxide
- atracurium
- atropine
- axitinib
- azelaic acid
- Erythema: 1% - 2%
- Redness
- aztreonam
- bendamustine
- benzocaine
- benzoyl
- benzyl alcohol
- betamethasone dipropionate
- betamethasone valerate
- betaxolol
- bexarotene
- bezafibrate
- bimatoprost
- Erythema: postmarketing
- Erythema periorbital
- bisoprolol
- bleomycin hydrochloride
- boceprevir
- bortezomib
- bosentan
- brimonidine
- Erythema: postmarketing, common, 0.906% - 8%
- Skin warm: 0% - 0.909%
- Erythema facial
- brinzolamide
- bupivacaine
- buprenorphine
- buspirone
- Erythema: rare
- Redness: infrequent
- busulfan
- butenafine
- butorphanol
- cabazitaxel
- cabozantinib
- calcipotriol
- canagliflozin
- capecitabine
- Erythema: 1% - 6%
- Redness of face
- capsaicin
- carbamazepine
- carboplatin
- cefepime
- cefoxitin
- cefprozil
- ceftaroline
- ceftobiprole
- cefuroxime
- cefuroxime axetil
- cetrorelix
- chlorhexidine
- chloroprocaine
- ciclopirox
- Erythema: common
- Periungual erythema
- ciprofloxacin
- Erythema: 1.2%
- Redness: 1.2%
- cisatracurium
- cisplatin
- citalopram
- cladribine
- Erythema: common, 6%
- Redness
- clindamycin
- Erythema: 0.595% - 86%
- Redness
- Localized erythema
- clindamycin phosphate
- clobetasol
- clobetasol propionate
- clobetasone butyrate
- clofarabine
- clomiphene citrate
- clonidine
- clotrimazole
- clozapine
- codeine
- conivaptan
- conjugated estrogens
- copolymer 1
- cortisol
- Erythema: postmarketing, 1.44% - 13.8%
- Erythema facial
- Redness: 1%
- cortisone
- cosyntropin
- cyclizine
- cyclophosphamide
- Erythema: postmarketing
- Redness
- cysteamine
- cytokinin
- dabrafenib
- Erythema: common, 0% - 15%
- dalteparin
- dantrolene
- dapsone
- darunavir
- dasatinib
- deferoxamine
- degarelix
- delavirdine
- demethyl
- deprenyl
- desflurane
- desloratadine
- desmopressin
- desonide
- desoximetasone
- dexamethasone
- dexamethasone sodium phosphate
- dexrazoxane
- diatrizoate
- diazepam
- diclofenac
- Erythema: very rare, infrequent, 4%
- Redness
- dicyclomine
- diethylpropion
- diltiazem
- docetaxel
- Erythema: postmarketing
- Redness: 3.3% - 5.6%
- donepezil
- dorzolamide
- doxepin
- doxorubicin
- Erythema: postmarketing
- Redness
- doxycycline
- doxycycline hyclate
- dronedarone
- duloxetine
- Erythema: postmarketing, infrequent
- ecallantide
- echothiophate
- econazole
- efavirenz
- epinephrine
- eribulin
- erlotinib
- ertapenem
- erythromycin
- eslicarbazepine acetate
- esmolol
- estradiol
- Erythema: postmarketing
- Redness
- etidronate
- etoricoxib
- everolimus
- Erythema: uncommon, common, 4%
- exenatide
- ezetimibe
- febuxostat
- felodipine
- fenofibrate
- fentanyl
- Erythema: very rare, postmarketing, 1% - 3%
- florbetaben
- fludrocortisone
- fludrocortisone acetate
- flumazenil
- fluocinolone acetonide
- fluocinonide
- fluorescein
- fluphenazine
- fluphenazine decanoate
- flutamide
- fluticasone
- Erythema: postmarketing, 0% - 2%
- fluticasone propionate
- fluvastatin
- folate
- fosaprepitant
- fosaprepitant dimeglumine
- fotemustine
- furosemide
- fusidic acid
- gabapentin
- gadobenate dimeglumine
- gadofosveset
- gadolinium
- gadoteridol
- gadoversetamide
- gatifloxacin
- gemcitabine
- gentamicin
- glibenclamide
- gliclazide
- glimepiride
- glipizide
- glycerol
- glycopyrrolate
- gold sodium thiomalate
- gonadorelin
- griseofulvin
- halcinonide
- halobetasol
- heparin
- hepatitis B vaccines
- Erythema
- Redness: very common
- hexachlorophene
- histamine
- hydrochlorothiazide
- hydromorphone
- hydroxocobalamin
- hydroxyurea
- ibandronate
- ibuprofen
- icodextrin
- Erythema: postmarketing
- Redness
- ifosfamide
- imatinib
- imiquimod
- Erythema: uncommon, 0% - 100%
- indapamide
- indomethacin
- insulin detemir
- Redness
- Localized erythema
- iodixanol
- iohexol
- iopromide
- iotrolan
- ioversol
- ioxaglate
- irbesartan
- Erythema
- Erythema facial: uncommon
- irbesartan-hydrochlorothiazide
- iron sucrose
- ivabradine
- ketamine
- ketoconazole
- ketoprofen
- ketorolac tromethamine
- labetalol
- lacosamide
- lactate
- lamivudine
- lamotrigine
- Erythema: rare, infrequent
- lansoprazole
- lasofoxifene
- latanoprost
- lenalidomide
- lercanidipine
- leucovorin
- leuprorelin acetate
- levocabastine
- levonorgestrel
- lidocaine
- linezolid
- liraglutide
- lorazepam
- losartan
- lubiprostone
- mTHPC
- mafenide acetate
- malvidin
- maraviroc
- medroxyprogesterone
- medroxyprogesterone acetate
- mefloquine
- melatonin
- meloxicam
- meperidine
- mepivacaine
- meropenem
- mesna
- metformin
- methadone
- methohexital
- methotrexate
- methyl aminolevulinate
- Erythema: postmarketing, 0% - 63.5%
- Skin warm: 0% - 3.97%
- methylnaltrexone
- methylphenidate
- methylprednisolone
- methylprednisolone sodium succinate
- metronidazole
- Erythema: 1% - 2%
- Redness
- midazolam
- Erythema
- Redness: 0.5% - 3.8%
- mipomersen
- mitomycin C
- mitoxantrone
- mivacurium
- mometasone furoate
- monomethylfumarate
- morphine
- moxifloxacin
- mupirocin
- naftifine
- Erythema: postmarketing, 0.5% - 2%
- Redness: postmarketing
- nalbuphine
- nalidixic acid
- naphazoline
- naproxen
- naratriptan
- nelfinavir
- neomycin
- nevirapine
- niacin
- nicotine
- nifedipine
- nilotinib
- Erythema: common, 0% - 6%
- nitroglycerin
- norfloxacin
- Erythema
- Erythema periorbital: postmarketing
- ofloxacin
- ogen
- olanzapine
- olopatadine
- olsalazine
- ondansetron
- oxaliplatin
- oxiconazole
- oxybutynin
- paclitaxel
- Erythema: postmarketing, rare, uncommon, common, very common
- Redness: postmarketing
- paliperidone
- palonosetron
- pamidronate
- pancuronium
- paroxetine
- pazopanib
- pemetrexed
- penciclovir
- pentamidine
- pentoxifylline
- perindopril
- perindopril erbumine
- permethrin
- perphenazine
- phencyclidine
- phenobarbital
- phenyllactate
- pimecrolimus
- piperacillin
- pirfenidone
- piroxicam
- pixantrone
- podophyllotoxin
- ponatinib
- posaconazole
- pramipexole
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- procaine
- prochlorperazine
- progesterone
- proguanil
- promethazine
- propafenone
- propofol
- propranolol
- quinidine
- quinol
- rabeprazole
- radium
- raltegravir
- ramipril
- ranitidine
- regadenoson
- remifentanil
- repaglinide
- rescinnamine
- retapamulin
- retinoic acid
- Erythema: very common, 0.205% - 41%
- Redness: very common
- Erythema facial: postmarketing
- ribavirin
- risperidone
- rivastigmine
- Erythema: postmarketing, infrequent, 1.1%
- rizatriptan
- rofecoxib
- ropivacaine
- rotigotine
- salicylate
- salmon calcitonin acetate
- saquinavir
- scopolamine
- Erythema: postmarketing
- Redness
- sertaconazole
- sertraline
- sildenafil
- Erythema: 1% - 6%
- Redness: postmarketing
- simvastatin
- sodium cromoglycate
- sodium ferric gluconate
- sodium iothalamate
- sorafenib
- Erythema: postmarketing, very common
- spinosad
- streptozotocin
- sufentanil
- sulconazole
- sulfacetamide
- sulfasalazine
- sumatriptan
- Erythema: postmarketing, infrequent
- Redness: postmarketing
- Redness of face
- sunitinib
- suprofen
- tacrolimus
- tamoxifen
- tazarotene
- technetium-99m
- telavancin
- telmisartan
- Erythema: postmarketing, rare
- temozolomide
- Erythema: uncommon, common, 0% - 5.26%
- temsirolimus
- tenoxicam
- terbinafine
- Erythema: common, 0.9% - 9%
- Redness
- testolactone
- testosterone
- Erythema: postmarketing, common, 8%
- testosterone undecanoate
- tetrahydrozoline
- thiazide
- thioridazine
- thiotepa
- tiaprofenic acid
- timolol
- tipranavir
- tobramycin
- tofacitinib
- tolazamide
- tolbutamide
- topiramate
- tramadol
- Erythema: postmarketing, uncommon
- trametinib
- travoprost
- treprostinil
- triamcinolone
- triamcinolone acetonide
- triazolam
- trifluoperazine
- trimethoprim
- tropisetron
- vardenafil
- varenicline
- Erythema: infrequent, uncommon
- vecuronium
- vemurafenib
- Erythema: postmarketing, 0% - 14%
- venlafaxine
- vinflunine
- vinorelbine
- vitamin K
- voriconazole
- x M22
- zidovudine
- ziprasidone
- zoledronic acid
- Erythema
- Redness: uncommon
- zolmitriptan
- zolpidem
- zuclopenthixol
|
Drugs with this indication
|